Overview
Apartment and camper rental, property management, and renovations.
Deals · 12mo
2
Links
Stage focus
Geographic focus
Sector focus
Investment portfolio
- Colossal Biosciences
Participated · Equity · Aug 2026
Colossal Biosciences focuses on applying AI to biological questions, including predicting how biological systems fail or break. The company is co-founded by Ben Lamm and has been associated publicly with figures such as George Church, Beth Shapiro, and Adam Milne. Financially, Colossal announced a $20 million financing at a $3.8 billion valuation. The recent capital raise is described as supporting its AI initiatives. The provided articles do not include revenue, user, or other operating metrics, nor do they state the company's founding year or location.
- Astromech
Participated · Equity · Aug 2026
Founded in September 2025 by Ben Lamm and George Church, Astromech trains AI on genomic data provided by Colossal to predict changes, vulnerabilities, and regulatory variation in living systems. Its first public project compares longevity- and cancer-related biology across species such as cancer-resistant Asian elephants, 200-year-old bowhead whales, and long-lived Brandt’s bats against shorter-lived relatives. The company reports having mapped 46 genes linked to cellular maintenance, cancer resistance, and longevity. Astromech positions its platform earlier in the discovery pipeline than many peers by forecasting where biological systems may fail before drug targets are identified. Competitors noted in coverage include Insitro and Isomorphic Labs, which operate in adjacent machine-learning-driven biology and drug-discovery spaces. Financially, the company has raised $60 million to date and now carries a reported valuation of $3.8 billion.